Home Sectors Healthcare Current Trend: Masimo Corporation (NASDAQ: MASI)

Current Trend: Masimo Corporation (NASDAQ: MASI)


Masimo Corporation is in the healthcare sector and is part of the medical instruments and equipment industry. The company CEO is Joseph E. Kiani. Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.

Previous Intraday Trading Performance:

The MASI stock showed a previous change of 0.70% with an open at 130.96 and a close of 131.84. It reached an intraday high of 132.34 and a low of 130.84.

Business Wire:  Masimo to Present at Barclays Global Healthcare Conference


The stock has a market cap of $7.0b with 53.2m shares outstanding, of which the float is 51.5m shares. Trading volume reached 223,415 shares compared to its average volume of 364,720 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Masimo Corporation shares returned 1.10% and in the past 30 trading days it returned 8.12%. Over three months, it changed 20.85%. In one year it has changed 48.20% and within that year its 52-week high was 135.75 and its 52-week low was 83.16. MASI stock is 58.54% above its 52 Week Low.

Our calculations show a 200 day moving average of 112.61 and a 50 day moving average of 122.46. Currently MASI stock is trading 17.08% above its 200 day moving average.

Business Wire:  Masimo to Present at Barclays Global Healthcare Conference


The last annual fiscal EPS for the company was reported at 3.49 that ended on 31st of December 2018, which according to the previous close, that is a PE of 37.78. Based on 4 analyst estimates, the consensus EPS for the next quarter is 0.72. The TTM EPS is 3.02, which comes to a TTM PE of 43.66. Historically, the PE high was 56.90 and the PE low was 11.80. If the stock reached its PE low, that would represent a price of 35.63, which is a decrease of -72.97%.

The following are the last four quarter reported earnings per share:
12-31-2018:  0.83
09-30-2018:  0.71
06-30-2018:  0.73
03-31-2018:  0.75

Base on our calculations, the intrinsic value per share is 56.68, which means it may be overvalued by -132.62%

Indicators to Watch:

Based on the latest filings, there is 137.30% of institutional ownership. Short-interest is 0, which is 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio is 0.00.

The current calculated beta is 1.19

Business Wire:  LifePoint Health and RCCH HealthCare Partners Announce Completion of Merger

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 23.29%, return on assets is 19.15%, profit margin is 23.53%, price-to-sales is 8.39 and price-to-book is 7.18.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 4  :Past Performance Score
 6  :Financial Strength Score
 2  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.